CeriBell, Inc. CBLL
Set alert
26.58 USD -1.24 -4.46%
At close · Oct 30
26.58 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
26.01 Day range 27.61
10.92 52-week range 27.82
- YTD
- +21.20%
- 1 year
- +134.81%
- Open
- 27.48
- Prev close
- 27.82
- Mkt cap
- 1.02B
- Vol
- 582.65K
- Avg vol
- 428.69K
- EPS
- -1.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.01
- High
- 27.61
- Forward P/E
- -16.48
- Beta
- 0.93
- Short ratio
- 5.05
- Inst. own
- 90.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 24.88
- 200-d avg
- 20.76
- 1y target
- 28.57
5Y chart
Events in this range
- Aug 5, 2025Earnings: -0.38; estimate -0.4; surprise 5%
- Nov 4, 2025Earnings: -0.37; estimate -0.43; surprise 13.95%
- Feb 24, 2026Earnings: -0.36; estimate -0.43; surprise 16.28%
- May 11, 2026Earnings: -0.52; estimate -0.39; surprise -33.33%
- May 12, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 10, 2026Earnings: -0.51; estimate -0.47119; surprise -8.24%
- Aug 11, 2026Rating: BTIG · Buy → Buy
- Aug 11, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 18, 2026Rating: BTIG · Buy → Buy
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Oct 2, 2026Rating: TD Cowen · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -0.5; surprise —%
Signals (30)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| RSI: Oversold | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Feb 17, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
Key statistics
- Market cap
- 1.02B
- Enterprise value
- 960.33M
- Trailing P/E
- 0.00
- Forward P/E
- -16.48
- PEG ratio
- 0.00
- Price / sales
- 10.00
- Price / book
- 7.92
- EPS (TTM)
- -1.76
- Beta
- 0.93
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -64.73%
- Revenue (TTM)
- 101.96M
- Revenue growth
- 32.50%
- Free cash flow
- -33.05M
- Total cash
- 129.26M
- Total debt
- 21.91M
- Return on equity
- -43.93%
- Shares outstanding
- 38.38M
- Short % of float
- 8.61%
- 50-day average
- 24.88
- 200-day average
- 20.76
Analyst view
Consensus: none
Price target (mean) 28.57 +7.5% upside
Now 26.58
- Target (low)
- 24.00
- Target (mean)
- 28.57
- Target (high)
- 33.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy1
- Buy7
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate -0.51532.
Financials — quick view
CBLL Revenue — quarterly 28.10M
CBLL Net income — quarterly -19.27M
CBLL EPS — quarterly -0.51
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | -0.50 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | -0.47119 | -0.51 | -0.04 | -8.24% |
| May 11, 2026 | Mar 31, 2026 | -0.39 | -0.52 | -0.13 | -33.33% |
| Feb 24, 2026 | Dec 31, 2025 | -0.43 | -0.36 | +0.07 | +16.28% |
| Nov 4, 2025 | Sep 30, 2025 | -0.43 | -0.37 | +0.06 | +13.95% |
| Aug 5, 2025 | Jun 30, 2025 | -0.40 | -0.38 | +0.02 | +5.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2026 | TD Cowen | main | Buy | Buy |
| Sep 11, 2026 | BTIG | reit | Buy | Buy |
| Aug 18, 2026 | BTIG | main | Buy | Buy |
| Aug 11, 2026 | Canaccord Genuity | main | Buy | Buy |
| Aug 11, 2026 | BTIG | reit | Buy | Buy |
| May 12, 2026 | Canaccord Genuity | main | Buy | Buy |
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- ceribell.com
News
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- TD Cowen Maintains Buy on CeriBell, Raises Price Target to $33
- Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
- BTIG Maintains Buy on CeriBell, Raises Price Target to $30
- Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $26
- CeriBell Raises FY2026 Sales Guidance from $112.000M-$116.000M to $114.000M-$117.000M vs $113.979M Est
- CeriBell Announces FDA 510(k) Clearance For Two New AI Algorithm Enhancements Integrated Directly Into Existing Cloud-Based Neurology Portal: Epileptiform Abnormality Detection And Artifact Reduction
- CeriBell Says U.S. CMS Grants New Technology Add-On Payment For Up To $2,171 Per Eligible Medicare Patient Case Utilizing Ceribell Delirium Monitor System
- CeriBell Highlights Publication Of New Research Paper, 'Point-Of-Care EEG Artificial Intelligence Measure Of Seizure Burden Associates With Clinical Outcome At Discharge'
- Canaccord Genuity Maintains Buy on CeriBell, Lowers Price Target to $25
Your note
Sign in to keep a note on CBLL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLUMBERG SCOTT | Chief Financial Officer | Sale | Sep 14, 2026 | 146,600 |
| CHAO XINGJUAN | Chief Executive Officer | Sale | Sep 14, 2026 | 1,115,430 |
| FOEHR DAVID | Officer | Sale | Sep 7, 2026 | 34,144 |
| MANNI JOSEPH S | Officer | Sale | Aug 20, 2026 | 55,956 |
| PARVIZI JOSEF | Director | Stock Award(Grant) | Jun 1, 2026 | 2,007,490 |
| ROGERS ERICA J. | Director | Stock Award(Grant) | Jun 1, 2026 | 33,054 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.83% | 5,691,393 | 151.28M | Jun 29, 2026 |
| TPG GP A, LLC | 9.80% | 3,761,154 | 99.97M | Jun 29, 2026 |
| Red Tree Management, LLC | 5.75% | 2,205,661 | 58.63M | Sep 29, 2026 |
| Blackrock Inc. | 5.04% | 1,936,093 | 51.46M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.95% | 1,130,346 | 30.04M | Jun 29, 2026 |
| KCM Capital Inc | 2.93% | 1,125,000 | 29.90M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 4.27% | 1,637,485 | 43.52M | Jul 30, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 2.61% | 1,002,889 | 26.66M | Jul 30, 2026 |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 2.45% | 939,251 | 24.97M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.22% | 850,443 | 22.60M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 2.16% | 830,545 | 22.08M | Jul 30, 2026 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 1.95% | 750,219 | 19.94M | Jul 30, 2026 |